Home/Rare Diseases/Giant Cell Arteritis

Autoimmune & Inflammatory

Giant Cell Arteritis

Also called GCA, Temporal Arteritis, Cranial Arteritis

Giant Cell Arteritis is a systemic vasculitis affecting large and medium-sized arteries, with primary involvement of the external carotid artery system and its branches, particularly the temporal artery. The disease results from T cell-mediated granulomatous inflammation with characteristic giant cells and macrophage infiltration of the vessel wall.

View active trialsMatch me to a trial

About Giant Cell Arteritis

Giant Cell Arteritis is a systemic vasculitis affecting large and medium-sized arteries, with primary involvement of the external carotid artery system and its branches, particularly the temporal artery. The disease results from T cell-mediated granulomatous inflammation with characteristic giant cells and macrophage infiltration of the vessel wall. Pathologic findings typically show granulomatous inflammation with giant cells centered at the internal elastic lamina. The inflammatory process causes vessel wall necrosis and intimal proliferation, leading to stenosis and ischemia in affected territories. Headache, often severe and localized to the temporal arteries, is the most common presenting symptom in 70%. Visual symptoms develop in 15-20% of untreated patients, including amaurosis fugax (transient vision loss) and permanent blindness from arteritic anterior ischemic optic neuropathy, a medical emergency requiring immediate high-dose corticosteroids. Jaw claudication (pain with mastication) is highly specific. Constitutional symptoms including fever, fatigue, and weight loss occur. Large vessel involvement (aorta, subclavian, axillary arteries) occurs in 10-15% and can cause significant ischemic complications. Polymyalgia rheumatica commonly co-occurs.

Common Symptoms

  • New-onset headaches in scalp, forehead, or temples
  • Jaw claudication (pain while chewing)
  • Vision loss or blindness from arteritic anterior ischemic optic neuropathy
  • Shoulder and hip pain from associated polymyalgia rheumatica
  • Fever and constitutional symptoms
  • Stroke from large vessel involvement

Who It Affects

Giant Cell Arteritis predominantly affects people over 50 years old, with median age of onset around 70-75 years. It affects females slightly more than males. The disease is much more common in people of Northern European descent (particularly Scandinavian, British, and Northern European ancestry) and rare in African, Native American, and Asian populations. About 40-60% of GCA patients have concurrent polymyalgia rheumatica.

Getting Involved in Clinical Trials

Clinical trials for Giant Cell Arteritis focus on corticosteroid-sparing strategies and newer biologic therapies, particularly TNF inhibitors and IL-6 inhibitors (tocilizumab), which have shown promise in clinical trials. Trials investigate optimal induction and maintenance therapy with goal of minimizing corticosteroid exposure while preventing relapses and ischemic complications. Management requires urgent diagnosis and treatment initiation to prevent vision loss. Patients should consult with a rheumatologist experienced in vasculitis.

Trusted Sources

Active Clinical Trials for Giant Cell Arteritis

Finding trials for Giant Cell Arteritis...

Related Autoimmune & Inflammatory Conditions

Autoimmune & Inflammatory

Takayasu Arteritis

Takayasu Arteritis is a rare chronic inflammatory disease of large arteries, particularly the aorta and its branches, ca...

Autoimmune & Inflammatory

Granulomatosis with Polyangiitis

Granulomatosis with Polyangiitis is a rare autoimmune disease causing inflammation of small and medium blood vessels in ...

Autoimmune & Inflammatory

Behçet Disease

Behçet Disease is a rare, chronic, recurrent vasculitis causing painful oral and genital ulcers, eye inflammation, and s...